q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

April 2019 Formularies Update: Seventy (70) Medications Added to Medicare Plan Drug Lists

Category: Monthly Formulary Changes
Published: Apr, 17 2019 11:04:34
< Previous
Next >
The April 2019 Medicare Part D plan formulary (drug lists) data includes the addition of 70 new National Drug Codes (NDCs) to the Medicare Part D program.  These NDCs represent 42 different drugs, many with multiple strengths.

New Generic Drugs Introduced: See our article https://Q1News.com/749.html for highlights of the new generics.

New Brand-Name Drugs Introduced
In addition, 15 new brand-name drugs, some with multiple strengths, were added to Medicare Part D plan formularies.  These drugs include, DAURISMO®, FIRVANQ®, INVELTYS®, LUXIQ®, NITYR®, OSMOLEX®, OXERVATE®, RETACRIT®, TEGSEDI®, TOLSURA®, UDENYCA®, VITRAKVI®, XELPROS®, XOSPATA®, ZONALON®.

What is the NDC?
The NDC uniquely identifies a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.  You can read more here: Q1FAQ.com/155

There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 70 new NDCs is as follows:

Reason for NDC Addition Occurrences
New Delivery Form 1
New Drug 19
New Drug and Strength 25
New Manufacturer 14
New Manufacturer and Delivery Form 2
New Manufacturer and Strength 3
New Manufacturer, Strength and Delivery Form 1
New Packaging 2
New Strength 3
Total New NDCs 70

Reminder: (1) Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan. (2) Your Medicare Part D plan will notify you if the plan drops a medication you are currently using.

The following chart details the first 70 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates. You can click on the Drug Code (NDC) or Drug Name below to go to our Q1Medicare.com Drug Finder (Q1Rx.com) to see the details of how this drug is covered by all Medicare Part D Plans in Florida -- You can then change the state to your state for details in your service area.


NDC Drug Name Notes
50242014301ACTEMRA ACTPEN 162 MG/0.9 ML PEN INJCTRNew Delivery Form
00023599060ANDRODERM 2 MG/24HR PATCHNew Strength
00069153130DAURISMO 100 MG TABLETNew Drug and Strength
00069029860DAURISMO 25 MG TABLETNew Drug and Strength
00006046405EMEND 40 MG CAPSULENew Strength
50222050550FINACEA 15% GELNew Manufacturer and Delivery Form
65628020510FIRVANQ 25 MG/ML SOLUTION SOLN RECONNew Drug and Strength
65628020810FIRVANQ 50 MG/ML SOLUTION SOLN RECONNew Drug and Strength
68462073129HAILEY 24 FE 1 MG-20 MCG TABLET [Tarina Fe 1/20]New Drug
42543014201HYDROCORTISONE 20 MG TABLET [Cortef]New Drug and Strength
42543014050HYDROCORTISONE 5 MG TABLET [Cortef]New Drug and Strength
42543014101HYDROCORTISONE 10 MG TABLET [Hydrocortone]New Drug and Strength
71571012128INVELTYS 1% EYE DROP Eye DropperNew Drug
70688050202KYNAMRO 200 MG/ML SYRINGENew Packaging
13668004501LAMOTRIGINE 25 MG TABLET [Subvenite]New Drug
00115993076LEVALBUTEROL 0.31 MG/3 ML SOL VIAL-NEB [Xopenex Pediatric]New Manufacturer and Strength
43598041025LEVALBUTEROL 0.63 MG/3 ML SOL VIAL-NEB [Xopenex]New Manufacturer and Strength
43598040925LEVALBUTEROL 1.25 MG/3 ML SOL VIAL-NEB [Xopenex]New Manufacturer and Strength
00378818701LUXIQ 0.12% FOAMNew Drug
00378923093MESALAMINE 1,000 MG SUPP.RECT [Canasa]New Drug
51991061250METHYLPHENIDATE 10 MG/5 ML SOL Solution [Methylin]New Manufacturer, Strength and Delivery Form
51991061150METHYLPHENIDATE 5 MG/5 ML SOLN Solution [Methylin]New Manufacturer and Delivery Form
42806009430POTASSIUM CL 20 MEQ PACKET [Klor-Con]New Drug
16714043901NITROFURANTOIN MONO-MCR 100 MG CAPSULE [Macrobid]New Drug
70709000060NITYR 10 MG TABLETNew Drug and Strength
70709000260NITYR 2 MG TABLETNew Drug and Strength
70709000560NITYR 5 MG TABLETNew Drug and Strength
00378818201OLUX 0.05% FOAMNew Manufacturer
68025007530OSMOLEX ER 129 MG TABLET BP 24HNew Drug and Strength
68025007630OSMOLEX ER 193 MG TABLET BP 24HNew Drug and Strength
68025007730OSMOLEX ER 258 MG TABLET BP 24HNew Drug and Strength
71981002007OXERVATE 0.002% EYE DROPSNew Drug
43598035001PROGESTERONE 200 MG CAPSULE [Prometrium]New Drug
00069130810RETACRIT 10,000 UNIT/ML VIALNew Drug and Strength
00069130510RETACRIT 2,000 UNIT/ML VIALNew Drug and Strength
00069130610RETACRIT 3,000 UNIT/ML VIALNew Drug and Strength
00069130710RETACRIT 4,000 UNIT/ML VIALNew Drug and Strength
00069130904RETACRIT 40,000 UNIT/ML VIALNew Drug and Strength
29300031781RIZATRIPTAN 10 MG TABLET [Maxalt]New Drug and Strength
51991035478RIZATRIPTAN 5 MG TABLET [Maxalt]New Drug and Strength
59651009530SILODOSIN 4 MG CAPSULE [Rapaflo]New Drug and Strength
59651009630SILODOSIN 8 MG CAPSULE [Rapaflo]New Drug and Strength
65862005090SIMVASTATIN 5 MG TABLET [Zocor]New Drug
67457087905SUMATRIPTAN 6 MG/0.5 ML SYRNG Syringe [Sumavel DosePro System]New Drug
72126000701TEGSEDI 284 MG/1.5 ML SYRINGENew Drug
68462020113TELMISARTAN 80 MG TABLET [Micardis]New Strength
71858003004TIROSINT 100 MCG CAPSULENew Manufacturer
71858003504TIROSINT 112 MCG CAPSULENew Manufacturer
71858004004TIROSINT 125 MCG CAPSULENew Manufacturer
71858000504TIROSINT 13 MCG CAPSULENew Manufacturer
71858004504TIROSINT 137 MCG CAPSULENew Manufacturer
71858005004TIROSINT 150 MCG CAPSULENew Manufacturer
71858005504TIROSINT 175 MCG CAPSULENew Manufacturer
71858006004TIROSINT 200 MCG CAPSULENew Manufacturer
71858001004TIROSINT 25 MCG CAPSULENew Manufacturer
71858001504TIROSINT 50 MCG CAPSULENew Manufacturer
71858002004TIROSINT 75 MCG CAPSULENew Manufacturer
71858002504TIROSINT 88 MCG CAPSULENew Manufacturer
51862046260TOLSURA 65 MG CAPSULE SD DSPNew Drug
70700012184TRI-ESTARYLLA TABLET [Trinessa]New Drug
50458051560TYLENOL WITH CODEINE #4 TABLETNew Packaging
70114010101UDENYCA 6 MG/0.6 ML SYRINGENew Drug
69639012001VALCHLOR 0.016% GELNew Manufacturer
00074305413VICODIN HP 10-300 MG TABLET [Xodol]New Drug
71777039101VITRAKVI 100 MG CAPSULENew Drug and Strength
71777039201VITRAKVI 20 MG/ML SOLUTIONNew Drug and Strength
71777039001VITRAKVI 25 MG CAPSULENew Drug and Strength
47335031790XELPROS 0.005% EYE DROPS EMULSNew Drug
00469142590XOSPATA 40 MG TABLETNew Drug
00378812345ZONALON 5% CREAM (g)New Drug





Our online Formulary Browser and Drug Finder
You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at: Q1Rx.com.

Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
September 2023, September 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting Your Medicare Plan
Star Ratings & Plan Quality
Annual Medicare Plan Changes
Enrollment Topics
Late Enrollment Penalty
Your Formulary (Drug List)
Monthly Formulary Changes
Your Medicare Plan Coverage
Pharmacies & Providers
Changing Medicare Plans
Special Enrollment Periods SEP
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and High Costs
Out of Pocket: TrOOP and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for Higher Incomes
Medicare Advantage Plans MAPD
Medicare Supplements - Medigap
Medicare Plan Providers
Marketing Medicare Products
General Medicare Part D PDP
General Medicare
Diabetes and Diabetic Coverage
Your Health & Wellness
About Q1Medicare.com


Prescription Discounts for the Whole Family
Prescription Discounts are
easy as 1-2-3
  1. Locate lowest price drug and pharmacy
  2. Show card at pharmacy
  3. Get instant savings!
» Compare prices at pharmacies near you.
Your drug discount card is available to you at no cost.


© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.